Clearance Summary
KLEENASEPTIC received FDA 510(k) clearance under submission number K981023, sponsored by Metrex Research Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 1998-04-30.
- Submission: K981023
- Applicant / Sponsor: Metrex Research Corp.
- Clearance pathway: Traditional
- Review panel: General Hospital
- Device class: Class I
- Regulation citation: 21 CFR 880.6890
- Decision date: 1998-04-30
Classification & Regulation
This clearance is catalogued under FDA product code LRJ and 21 CFR 880.6890, within the General Hospital review panel as a Class I device.